VivoSeq
Other

Vasodilation

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Vasodilation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

60/100

Attrition Rate

27/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

15

clinical trials

Completed6 · 40%
Recruiting2 · 13%
Unknown status2 · 13%
Withdrawn2 · 13%
Terminated2 · 13%
Active, not recruiting1 · 7%

Trial Activity

15 trials

Topical Radial Artery Vasodilation
Completed·UUniversity of California, San Francisco·Phase 2/3·NCT01155167·86 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)